State of Wisconsin Investment Board’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
State of Wisconsin Investment Board's BEAM Position: Q1 2026 in Review
State of Wisconsin Investment Board reduced its Beam Therapeutics (BEAM) stake by 2.2% in Q1 2026, selling an estimated $36.3K and leaving 57,217 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1551.
State of Wisconsin Investment Board first reported a position in BEAM in Q1 2020 and has held it in 25 quarters since. The position peaked at $8.37M in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.
- State of Wisconsin Investment Board held 57,217 shares of Beam Therapeutics worth $1.36M as of Q1 2026.
- State of Wisconsin Investment Board sold 1,309 Beam Therapeutics shares in Q1 2026, an estimated $36.3K.
- Beam Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1551 holding.
- State of Wisconsin Investment Board first reported a position in Beam Therapeutics in Q1 2020 and has held it in 25 quarters since.
- State of Wisconsin Investment Board's Beam Therapeutics position peaked at $8.37M in Q2 2021.
- 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.